KR880009653A - 혈액중 요산농도를 감소시키는데 유용한 치료제 - Google Patents

혈액중 요산농도를 감소시키는데 유용한 치료제 Download PDF

Info

Publication number
KR880009653A
KR880009653A KR1019880002083A KR880002083A KR880009653A KR 880009653 A KR880009653 A KR 880009653A KR 1019880002083 A KR1019880002083 A KR 1019880002083A KR 880002083 A KR880002083 A KR 880002083A KR 880009653 A KR880009653 A KR 880009653A
Authority
KR
South Korea
Prior art keywords
salts
pharmaceutically acceptable
acid
acceptable salt
fluorobenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019880002083A
Other languages
English (en)
Korean (ko)
Inventor
트리붸 씨럼 페르
Original Assignee
원본미기재
임페리얼 케미칼 인더스트리스 아메리카스 인코오포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 임페리얼 케미칼 인더스트리스 아메리카스 인코오포레이티드 filed Critical 원본미기재
Publication of KR880009653A publication Critical patent/KR880009653A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Semiconductor Lasers (AREA)
KR1019880002083A 1987-02-26 1988-02-26 혈액중 요산농도를 감소시키는데 유용한 치료제 Ceased KR880009653A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878704569A GB8704569D0 (en) 1987-02-26 1987-02-26 Therapeutic agent
US8704569 1987-02-26

Publications (1)

Publication Number Publication Date
KR880009653A true KR880009653A (ko) 1988-10-04

Family

ID=10613007

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880002083A Ceased KR880009653A (ko) 1987-02-26 1988-02-26 혈액중 요산농도를 감소시키는데 유용한 치료제

Country Status (12)

Country Link
US (1) US4895843A (enExample)
EP (1) EP0296695B1 (enExample)
JP (1) JPH01216931A (enExample)
KR (1) KR880009653A (enExample)
AT (1) ATE81005T1 (enExample)
DE (1) DE3874978T2 (enExample)
DK (1) DK169304B1 (enExample)
ES (1) ES2052701T3 (enExample)
GB (2) GB8704569D0 (enExample)
GR (1) GR3006256T3 (enExample)
HU (1) HU197845B (enExample)
IE (1) IE61934B1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
CA2685202C (en) 2007-03-23 2017-11-28 The Board Of Regents Of The University Of Texas System Methods for treating allergic asthma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture

Also Published As

Publication number Publication date
GR3006256T3 (enExample) 1993-06-21
HUT46213A (en) 1988-10-28
DK99488D0 (da) 1988-02-25
IE61934B1 (en) 1994-11-30
ES2052701T3 (es) 1994-07-16
EP0296695A2 (en) 1988-12-28
HU197845B (en) 1989-06-28
GB2201343B (en) 1990-11-14
DE3874978T2 (de) 1993-02-18
ATE81005T1 (de) 1992-10-15
US4895843A (en) 1990-01-23
GB2201343A (en) 1988-09-01
EP0296695B1 (en) 1992-09-30
EP0296695A3 (en) 1990-07-18
JPH01216931A (ja) 1989-08-30
DK169304B1 (da) 1994-10-10
GB8704569D0 (en) 1987-04-01
DK99488A (da) 1988-08-27
DE3874978D1 (de) 1992-11-05
GB8803763D0 (en) 1988-03-16
IE880515L (en) 1988-08-26

Similar Documents

Publication Publication Date Title
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
ATE113213T1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DK261490D0 (da) New pharmaceutical compound
IE41374B1 (en) A composition for treating schizophrenia
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
DE3778770D1 (de) Neue diphenylpropylamin-derivate, ihre herstellung sowie ihre pharmazeutische verwendung.
DE69914084D1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
KR920004391A (ko) 치환된 카복실산의 코데인 염, 이의 제조방법, 이의 용도 및 약제학적 조성물
KR970025615A (ko) 암 전이 억제제
KR950703527A (ko) 프로스타글란딘 유도체
DE58906387D1 (de) Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica.
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
KR950032191A (ko) 사이클로헥산 유도체, 이의 제조방법 및 질병을 치료하기 위한 화합물의 용도
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
BRPI0514891A (pt) composição contendo derivados de prostaglandina e uso da referida composição
KR890001540A (ko) 심부전증 치료제
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
KR900701273A (ko) 진토성 에르골린 유도체

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880226

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19930223

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19880226

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19960326

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19960726

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19960326

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I